Covishield maker Serum Institute of India's CEO Adar Poonawalla lauded the government's decision to increase the gap between two Covishield doses to 12-16 weeks, calling it a "good scientific decision." He told NDTV, "This is a very good move because it's based on data that the government received." He added, "This is beneficial both from the efficacy and immunogenicity standpoint."
 

Covishield maker Serum Institute of India's CEO Adar Poonawalla lauded the government's decision to increase the gap between two Covishield doses to 12-16 weeks, calling it a "good scientific decision." He told NDTV, "This is a very good move because it's based on data that the government received." He added, "This is beneficial both from the efficacy and immunogenicity standpoint."